• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2016, Vol. 18 ›› Issue (2): 114-117.DOI: 10.3969/j.issn.1671-2587.2016.02.007

• 临床输血研究 • 上一篇    下一篇

KDIGO标准在MODS合并AKI患者选择血液净化治疗时机中的临床意义

黄浩,汪薇,柳林伟   

  1. 431700 湖北省天门市第一人民医院肾内科
  • 收稿日期:2015-10-12 修回日期:2016-09-21 出版日期:2016-04-20 发布日期:2016-09-21
  • 作者简介:黄浩(1980-),男,湖北钟祥人,主治医师,硕士,主要从事肾病内科相关临床与科研工作,(Tel)13707222829(E-mail)huanghao988@yeah.net。

Clinical Significance of KDIGO Standards in the Patients with MODS Combined with AKI in Time Selection for Blood Purification Therapy

HUANG Hao, WANG Wei, LIU Lin-wei   

  1. Department of Renal Internal Medicine, Tianmen First People' s Hospital, Tianmen Hubei, 431700
  • Received:2015-10-12 Revised:2016-09-21 Online:2016-04-20 Published:2016-09-21

摘要: 目的探讨KIDGO标准在MODS合并AKI患者选择血液净化治疗时机中的临床意义。方法选取本院150例MODS合并AKI需要进行血液净化治疗的患者,根据KDIGO标准和APACHEⅡ评分将其分为KDIGO 1、2、3期三组和APACHEⅡ评分<15分、15~25分、>25分三组。分别对各组患者的存活率、存活患者肾功能改善率、平均住院时间、治疗费用及CBP治疗超滤总量进行比较。结果KDIGO 1、2期的患者存活率、存活患者肾功能改善率、平均住院时间、治疗费用及CBP治疗超滤总量均显著优于APACHEⅡ评分≤25分的患者,差异具有统计学意义(P<0.05)。KDIGO 3期患者的存活率、存活患者肾功能改善率、平均住院时间、治疗费用及CBP治疗超滤总量,与APACHEⅡ评分>25分患者的差异无统计学意义(P>0.05)。结论KDIGO 1、2期对患者进行血液净化治疗可显著提高治疗效果。

关键词: KDIGO标准, 多器官功能障碍综合征, 急性肾损伤, 血液净化治疗时机, APACHEⅡ

Abstract: ObjectiveTo explore the clinical significance of KDIGO standards in the patients with MODS combined with AKI for the time selection of blood purification therapy. Method150 patients with MODS/AKI were selected in our hospital who needed blood purification, and then were divided into three groups of KDIGO 1,2,3 according to the KDIGO criteria and three groups of APACHEⅡ scored <15,15 to 25,> 25 according to the APACHEⅡ criteria. The survival rate of patients in each group and the renal function improvement, average length of being hospitalized, cost of treatment and the total amount of CBP ultrafiltration treatment were respectively compared. ResultThe survival rates, renal function improvement, the average length of being hospitalized, the total cost of treatment and ultrafiltration of CBP treatment of the KDIGO1,2 patients were significantly better than patients whose APACHEⅡscore≤25 points, the difference was statistically significant(P<0.05). KDIGO3 patients’ survival rates, renal function improved survival rates, average length of stay, treatment costs and CBP treatment’s total ultrafiltration had no significant difference with patients in group of APACHEⅡscore>25(P>0.05). ConclusionThe blood purification treatment on the patients in the period of KDIGO1 and 2 can significantly improve the therapeutic effect.

Key words: KDIGO, standards, MODS, AKI, Intervention, time, of, the, blood, purification, APACHEⅡ

中图分类号: